Exact Sciences
Madison, Wisconsinexactsciences.com
Overview
Exact Sciences Corp. is a molecular diagnostic company specializing in the detection of early-stage cancers . The company's initial focus was on early detection and prevention of colorectal cancer; its stool DNA test, Cologuard, was launched in 2014 . Exact Sciences also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| KeyCare | Mar 2026 | Early Funding | Co-investor |
| Tri County Community Health Council | Dec 2023 | Grant | Lead |
| Thrive Earlier Detection | Jan 2021 | M&A | Co-investor |
| Thrive Earlier Detection | Oct 2020 | M&A | Co-investor |
| Thrive Earlier Detection | Jul 2020 | Series B | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
